MORIMOTO Satoshi    Department   School of Medicine(Tokyo Women's Medical University Hospital), School of Medicine    Position   Associate Professor
Article types	Original article
Language	English
Peer review	Peer reviewed
Title	Prediction of gestational diabetes mellitus by soluble (pro)renin receptor during the first trimester.
Journal	Formal name：The Journal of clinical endocrinology and metabolism Abbreviation：J Clin Endocrinol Metab ISSN code：1945-7197(Electronic)0021-972X(Linking)
Volume, Issue, Page	98(6),pp.2528-35
Author and coauthor	WATANABE Noriyoshi†, MORIMOTO Satoshi, FUJIWARA Takeo, SUZUKI Tomo, TANIGUCHI Kosuke, MORI Fumiko, ANDO Takashi, WATANABE Daisuke, KIMURA Tadashi, SAGO Haruhiko, ICHIHARA Atsuhiro*
Publication date	2013/06
Summary	CONTEXT:There are currently no factors that have been shown to predict gestational diabetes mellitus (GDM) during early pregnancy. The soluble (pro)renin receptor [s(P)RRCONTEXT:]CONTEXT:may contribute to the development of GDM.OBJECTIVE:The objective of the study was to determine whether plasma s(P)RR concentrations during early pregnancy are associated with the development of GDM later in pregnancy.DESIGN, SETTING, AND PARTICIPANTS:This prospective cohort study was conducted at a referral birth center. Pregnant women who first visited our hospital during the first trimester (DESIGN, SETTING, AND PARTICIPANTS:<DESIGN, SETTING, AND PARTICIPANTS:14 weeks of gestation) between 2010 and 2011 were enrolled. Inclusion criteria included singleton pregnancy and the absence of preexisting diabetes mellitus. A total of 716 women participated in this study.MAIN OUTCOME MEASURE:The association of plasma s(P)RR concentrationsMAIN OUTCOME MEASURE:with the onset of GDM later in pregnancy was measured.RESULTS:Among 716 participants, 44 (6.1%) had GDM and 672 (93.9%) did not. There were 176 participants in the first plasma s(P)RR concentration quartile (Q1:RESULTS:<RESULTS:25.8 ng/mL), 179 in the second (Q2: 25.8-30.2 ng/mL), 181 in the third (Q3: 30.2-34.2 ng/mL), and 180 in the fourth (Q4:RESULTS:>RESULTS:34.2 ng/mL). GDM distribution was 7 (4.0%) in Q1, 5 (2.8%) in Q2, 13 (7.2%) in Q3, and 19 (10.6%) in Q4. A multivariate model adjusted for baseline characteristics, medical complications, and gestational characteristics revealed that the risk of developing GDM among women in Q4 compared with Q1 was 2.90 (95% confidence interval 1.11-7.49).CONCLUSION:Increased s(P)RR concentrations during the first trimester may predict the development of GDM later in pregnancy.
DOI	10.1210/jc.2012-4139
Document No.	23720787